Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004185871> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2004185871 endingPage "360" @default.
- W2004185871 startingPage "352" @default.
- W2004185871 abstract "The antihypertensive efficacy and side effects of the combined therapy with propranolol, phenoxybenzamine, and hydrochlorothiazide were examined in 17 patients with moderate and moderately severe hypertension. Following a control period two to three weeks' duration, propranolol was started in nine patients as the sole antihypertensive agent and together with phenoxybenzamine, in eight. By titrating the dosage against pulse rate and blood pressure response, propranolol was given, in divided doses, from 80 to 160 mg and phenoxybenzamine, from 20 to 50 mg per day. When propranolol was given alone in nine patients, for four to 12 weeks, normal blood pressure was not attained in any patients. During three to ten weeks of combined propranolol and phenoxybenzamine therapy in 17 patients, normal blood pressure (150/90 mm Hg or less) or near-normal pressure (150/100 or less) was attained in 12 patients in the recumbent position and in 15 patients in the upright position, while orthostatic hypotension was not observed. Except for a reduction of ejaculation in three out of six male patients, no other side effects were encountered. The addition of hydrochlorothiazide diuretic in all of the above 17 patients, at a dose of 50-100 mg per day with a concomitant decrease in the dose of phenoxybenzamine, produced a further reduction in blood pressure, and normal or near-normal blood pressure was attained in all subjects. Symptomatic orthostatic hypotension, observed in two patients, was treated by a further readjustment of the dose of phenoxybenzamine, while inhibition of ejaculation was persistent in only one patient. It is concluded that the combined administration of propranolol, phenoxybenzamine, and hydrochlorothiazide in individualized doses is very effective in lowering the blood pressure with minimal side effects." @default.
- W2004185871 created "2016-06-24" @default.
- W2004185871 creator A5048380141 @default.
- W2004185871 creator A5070348292 @default.
- W2004185871 date "1976-07-01" @default.
- W2004185871 modified "2023-10-05" @default.
- W2004185871 title "Alpha- and Beta-Adrenergic Receptor Blocking Agents Combined with a Diuretic in the Treatment of Essential Hypertension" @default.
- W2004185871 cites W1547854467 @default.
- W2004185871 cites W1968510500 @default.
- W2004185871 cites W1972264073 @default.
- W2004185871 cites W1975525940 @default.
- W2004185871 cites W1986280529 @default.
- W2004185871 cites W1994066244 @default.
- W2004185871 cites W2006183379 @default.
- W2004185871 cites W2014941345 @default.
- W2004185871 cites W2024885103 @default.
- W2004185871 cites W2027293154 @default.
- W2004185871 cites W2030146883 @default.
- W2004185871 cites W2047775602 @default.
- W2004185871 cites W2048830153 @default.
- W2004185871 cites W2057337047 @default.
- W2004185871 cites W2064085750 @default.
- W2004185871 cites W2088722766 @default.
- W2004185871 cites W2093005724 @default.
- W2004185871 cites W2114607443 @default.
- W2004185871 cites W2129605874 @default.
- W2004185871 cites W2158415162 @default.
- W2004185871 cites W2313044937 @default.
- W2004185871 cites W2405711231 @default.
- W2004185871 doi "https://doi.org/10.1002/j.1552-4604.1976.tb01532.x" @default.
- W2004185871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7576" @default.
- W2004185871 hasPublicationYear "1976" @default.
- W2004185871 type Work @default.
- W2004185871 sameAs 2004185871 @default.
- W2004185871 citedByCount "6" @default.
- W2004185871 crossrefType "journal-article" @default.
- W2004185871 hasAuthorship W2004185871A5048380141 @default.
- W2004185871 hasAuthorship W2004185871A5070348292 @default.
- W2004185871 hasConcept C126322002 @default.
- W2004185871 hasConcept C2777097880 @default.
- W2004185871 hasConcept C2778151854 @default.
- W2004185871 hasConcept C2779918671 @default.
- W2004185871 hasConcept C2780361556 @default.
- W2004185871 hasConcept C2780668150 @default.
- W2004185871 hasConcept C42219234 @default.
- W2004185871 hasConcept C71924100 @default.
- W2004185871 hasConcept C73787029 @default.
- W2004185871 hasConcept C84393581 @default.
- W2004185871 hasConceptScore W2004185871C126322002 @default.
- W2004185871 hasConceptScore W2004185871C2777097880 @default.
- W2004185871 hasConceptScore W2004185871C2778151854 @default.
- W2004185871 hasConceptScore W2004185871C2779918671 @default.
- W2004185871 hasConceptScore W2004185871C2780361556 @default.
- W2004185871 hasConceptScore W2004185871C2780668150 @default.
- W2004185871 hasConceptScore W2004185871C42219234 @default.
- W2004185871 hasConceptScore W2004185871C71924100 @default.
- W2004185871 hasConceptScore W2004185871C73787029 @default.
- W2004185871 hasConceptScore W2004185871C84393581 @default.
- W2004185871 hasIssue "7" @default.
- W2004185871 hasLocation W20041858711 @default.
- W2004185871 hasLocation W20041858712 @default.
- W2004185871 hasOpenAccess W2004185871 @default.
- W2004185871 hasPrimaryLocation W20041858711 @default.
- W2004185871 hasRelatedWork W1555858204 @default.
- W2004185871 hasRelatedWork W1969972005 @default.
- W2004185871 hasRelatedWork W1990107430 @default.
- W2004185871 hasRelatedWork W2071430338 @default.
- W2004185871 hasRelatedWork W2386248061 @default.
- W2004185871 hasRelatedWork W2398648196 @default.
- W2004185871 hasRelatedWork W2417067049 @default.
- W2004185871 hasRelatedWork W2465258953 @default.
- W2004185871 hasRelatedWork W2467868645 @default.
- W2004185871 hasRelatedWork W2186298615 @default.
- W2004185871 hasVolume "16" @default.
- W2004185871 isParatext "false" @default.
- W2004185871 isRetracted "false" @default.
- W2004185871 magId "2004185871" @default.
- W2004185871 workType "article" @default.